Driving CAR-T therapy safety and sustainability for the road ahead

Q&A with Abby McDonald, PhD, Solutions Development Supervisor

Subscribe

Get updates from the Cell Lines Blog delivered to your inbox.

An opportunity to impact the future of medicine

As told by Leah, Be The Match BioTherapies® allogeneic donor

The benefits of a Quality System Audit Program

Accelerate patient access to cell and gene therapies

Standardization in cell therapy industry is a race against time

Accellerate Summit highlights needs and challenges in standardization

The challenge of multiple audits and redundant training

A case study from UCLA Health

Developing and managing a strong collection center network

On-demand webinar available

Industry stakeholders propose unified CAR T toxicity grading scale

CIBMTR Cellular Therapy Registry recommended to meet outcomes data reporting requirements

Three things to know about efficient qualification of collection centers

‘There is no room for error’ in cell and gene therapy logistics

Delivering life-saving therapies on time, every time